Source: CVC IN BALTIMORE PROCEEDINGS
April 1, 2010
By:
Lauren A. Trepanier, DVM, PhD, DACVIM, DACVCP
The neonatal period is defined as from birth to 2-4 weeks of age for puppies and kittens, with the pediatric period defined as up to 12 weeks of age. Because of major changes in physiology during this period, drug disposition and response are likely to be varied.
|
Source: CVC IN BALTIMORE PROCEEDINGS
April 1, 2010
By:
Alan Chicoine, DVM, MSc, DACVP
Drug companies cannot supply labeled drug products to treat every condition in every species, and veterinarians often turn to extra-label drug use (ELDU) to fill these unmet therapeutic needs. A special form of ELDU is compounding medications.
|
Source: CVC IN BALTIMORE PROCEEDINGS
April 1, 2010
By:
Alan Chicoine, DVM, MSc, DACVP
Inflammation and pain are very common clinical problems in veterinary medicine. Although highly efficacious, use of non-steroidal anti-inflammatory drugs (NSAIDs) is not without risks, especially when used in geriatric or debilitated animals. Practitioners need a basic understanding of the action of these drugs in order to appreciate clinical differences between them.
|
Source: CVC IN BALTIMORE PROCEEDINGS
April 1, 2010
By:
Alan Chicoine, DVM, MSc, DACVP
With the increase in concurrent use in small animal patients, drug interactions are becoming more and more likely. Polypharmacy can have a number of unintended side effects.
|
Source: CVC IN SAN DIEGO PROCEEDINGS
November 1, 2009
By:
Butch KuKanich, DVM, PhD, DACVCP
The field of veterinary clinical pharmacology is growing tremendously with new veterinary drugs introduced and with the use of human labeled drugs in veterinary patients.
|
Source: CVC IN SAN DIEGO PROCEEDINGS
November 1, 2009
By:
Chantal Lainesse, DVM, PhD, DACVCP
Therapeutic drug monitoring (TDM) provides insight on the internal exposure of drug available to reach the site of action.
|
Source: CVC IN SAN DIEGO PROCEEDINGS
November 1, 2009
By:
Chantal Lainesse, DVM, PhD, DACVCP
Ever wondered how a veterinary generic drug is assumed to be interchangeable with the pioneer drug in a clinical setting?
|
Source: CVC IN SAN DIEGO PROCEEDINGS
November 1, 2009
By:
Butch KuKanich, DVM, PhD, DACVCP
Shock can be classified into general categories: hypovolemic, maldistribution, and cardiogenic.
|
|
